Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(40 sites)
United States
Clinical Research Site, Cullman, Alabama Clinical Research Site, Chandler, Arizona Clinical Research Site, Tucson, Arizona Clinical Research Site, Little Rock, Arkansas Clinical Research Site, Cerritos, California Clinical Research Site, Chula Vista, California Clinical Research Site, Huntington Beach, California Clinical Research Site, Long Beach, California Clinical Research Site, Santa Ana, California Clinical Research Site, Colorado Springs, Colorado Clinical Research Site, Brandon, Florida Clinical Research Site, Hialeah, Florida Clinical Research Site, Miami, Florida Clinical Research Site, Miami, Florida Clinical Research Site, Miami, Florida Clinical Research Site, Miami Lakes, Florida Clinical Research Site, Atlanta, Georgia Clinical Research Site, Stockbridge, Georgia Clinical Research Site, Towson, Maryland Clinical Research Site, Boston, Massachusetts Clinical Research Site, Lansing, Michigan Clinical Research Site, Novi, Michigan Clinical Research Site, Southfield, Michigan Clinical Research Site, Chesterfield, Missouri Clinical Research Site, St Louis, Missouri Clinical Research Site, Henderson, Nevada Clinical Research Site, Middletown, New Jersey Clinical Research Site, Denver, North Carolina Clinical Research Site, Fayetteville, North Carolina Clinical Research Site, Huntersville, North Carolina Clinical Research Site, Cincinnati, Ohio Clinical Research Site, Cincinnati, Ohio Clinical Research Site, Wyomissing, Pennsylvania Clinical Research Site, Charleston, South Carolina Clinical Research Site, Columbia, South Carolina Clinical Research Site, Houston, Texas Clinical Research Site, San Antonio, Texas Clinical Research Site, Sugar Land, Texas Canada
Clinical Research Site, Markham, Ontario Clinical Research Site, Toronto, Ontario